ea0070ep340 | Pituitary and Neuroendocrinology | ECE2020
Boertien Tessel M.
, Drent M.L.
, Booij Jan
, Majoie Charles B.L.M.
, Stokkel Marcel P.M.
, Hoogmoed Jantien
, Pereira Alberto M
, Biermasz Nienke
, Simsek Suat
, Veldman Ronald Groote
, Tanck Michael W.T.
, Fliers Eric
, Bisschop Peter H.
Rationale: At present, there is no approved medical treatment for patients with clinically non-functioning pituitary adenoma. A number of open-label studies suggest that treatment with somatostatin analogues may prevent tumour progression in selected patients. In vivo assessment of somatostatin receptor status using 68Ga-DOTATATE PET could help to select patients responsive to treatment.Trial objective: To investigate the effect of the somatosta...